Stelo by Dexcom is the first over-the-counter continuous glucose monitor (CGM) in the U.S. Though specifically designed for people with prediabetes or type 2 diabetes who don’t use insulin, anyone 18 ...

Abstract: The widespread adoption of the fifth generation (5G) of cellular networks has brought new opportunities for the development of localization-based services. High-accuracy positioning use ...

Dexcom are phasing out their Dexcom G6 continuous glucose monitor (CGM) and replacing it with the Dexcom G7.

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

According to Dexcom, the company’s new data emphasises the case to expand its CGM for people with all types of diabetes. Credit: Michael Vi / Shutterstock.com Dexcom is poised to share new data on the ...

Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reach among ...